免疫检查点B7-H3是前列腺癌中潜在的治疗点
Qi Shen1, Kaichen Zhou1, Haosen Lu2
1Jiangsu Key Laboratory of Biological Cancer Therapy, Xuzhou Medical University, Xuzhou, 221002, China.
Discover oncology
|December 22, 2024
概括
免疫检查点B7-H3 (CD276) 在瘤中显示双重效应,影响前列腺癌的进展. 了解其复杂的作用是开发B7-H3向癌症治疗的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 免疫检查点分子B7-H3 (CD276) 的高表达在许多癌症类型中被观察到,使其成为免疫治疗的重要目标.
- B7-H3在瘤微环境中表现出共抑制和共刺激功能,但控制其免疫反应的精确机制仍然不完全理解.
- B7-H3在前列腺癌中发挥着关键作用,影响瘤细胞迁移,入侵,血管生成,代谢重编程和抗化疗.
研究的目的:
- 审查目前关于前列腺癌中B7-H3分子机制的知识.
- 探索B7-H3的双重免疫功能及其在瘤进展中的非免疫介导作用.
- 讨论针对B7-H3治疗前列腺癌的治疗潜力.
主要方法:
- 文献综述综合了B7-H3.3的现有研究.
- 对研究B7-H3参与前列腺癌特征的研究进行分析.
- 对B7-H3.3的免疫和非免疫功能的证据评估.
主要成果:
- B7-H3涉及到关键的前列腺癌过程,包括转移,血管新生,新陈代谢和化学抵抗.
- B7-H3通过免疫调节和直接影响瘤进展的非免疫途径发挥影响.
- B7-H3功能的双重性质使预测其对抗瘤免疫反应的整体影响变得复杂.
结论:
- B7-H3是一种多方面的分子,对前列腺癌的发展和进展有重大影响.
- 准B7-H3作为前列腺癌的新治疗策略具有前景,需要进一步调查.
- 需要进一步的研究才能充分阐明B7-H3.3的复杂免疫和非免疫机制.
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:27Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
02:34Inhibition of Cdk Activity
4.6K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.6K